InBios International, Inc. is a biotechnology company specializing in the design, development and manufacture of immunodiagnostic devices for infectious diseases and biothreats. It offers FDA-cleared ELISA kits for Zika, dengue, and West Nile and rapid test kits for Chagas and leishmaniasis, as well as FDA EUA COVID-19 products. InBios also specializes in the development and manufacture of highly specific and well-characterized antibodies and antigens for use in infectious disease research.